You are here

Home » CERID Bibliography

CERID Bibliography

Export 49 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is HIV-1  [Clear All Filters]
2013
Gottlieb GS. Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1. AIDS. 2013 ;27(1):135-7.
2012
Kong R, Li H, Bibollet-Ruche F, Decker JM, Zheng NN, Gottlieb GS, Kiviat NB, Sow PSalif, Georgiev I, Hahn BH, et al. Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection. J Virol. 2012 ;86(2):947-60.
Pavlinac PB, Hawes SE, Gottlieb GS, Gaye A, N'Diaye CF, Critchlow CW, Sow PSalif, Feng Q, Kiviat NB. HIV shedding in the oral cavity: an assessment of HIV type, immunovirologic, demographic and oral factors. Sex Transm Infect. 2012 ;88(1):45-50.
Heitzinger K, Sow PS, Badiane NMDia, Gottlieb GS, N'Doye I, Toure M, Kiviat NB, Hawes SE. Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009. Int J STD AIDS. 2012 ;23(10):710-6.
Herbeck JT, Müller V, Maust BS, Ledergerber B, Torti C, Di Giambenedetto S, Gras L, Günthard HF, Jacobson LP, Mullins JI, et al. Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission. AIDS. 2012 ;26(2):193-205.
Doehle BP, Chang K, Rustagi A, McNevin J, McElrath JM, Gale M. Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism. J Virol. 2012 ;86(16):8367-74.
Doehle BP, Chang K, Fleming L, McNevin J, Hladik F, McElrath JM, Gale M. Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells. J Virol. 2012 ;86(16):8499-506.
2011
Zheng NN, McElrath JM, Sow PSalif, Mesher A, Hawes SE, Stern J, Gottlieb GS, De Rosa SC, Kiviat NB. Association between peripheral γδ T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa. J Acquir Immune Defic Syndr. 2011 ;57(2):92-100.
Harman AN, Lai J, Turville S, Samarajiwa S, Gray L, Marsden V, Mercier SK, Mercier S, Jones K, Nasr N, et al. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood. 2011 ;118(2):298-308.
Quakkelaar ED, Redeker A, Haddad EK, Harari A, McCaughey SM, Duhen T, Filali-Mouhim A, Goulet J-P, Loof NM, Ossendorp F, et al. Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PLoS One. 2011 ;6(2):e16819.
Smith RA, Raugi DN, Kiviat NB, Hawes SE, Mullins JI, Sow PS, Gottlieb GS. Phenotypic susceptibility of HIV-2 to raltegravir: integrase mutations Q148R and N155H confer raltegravir resistance. AIDS. 2011 ;25(18):2235-41.
Elahi S, Dinges WL, Lejarcegui N, Laing KJ, Collier AC, Koelle DM, McElrath JM, Horton H. Protective HIV-specific CD8+ T cells evade Treg cell suppression. Nat Med. 2011 ;17(8):989-95.
2010
Curlin ME, Zioni R, Hawes SE, Liu Y, Deng W, Gottlieb GS, Zhu T, Mullins JI. HIV-1 envelope subregion length variation during disease progression. PLoS Pathog. 2010 ;6(12):e1001228.
Gottlieb GS, Smith RA, Sow PSalif. Long-term nonprogressive disease among individuals with untreated HIV infection. JAMA. 2010 ;304(16):1784; author reply 1785-6.
Limou S, Coulonges C, Herbeck JT, van Manen D, An P, Le Clerc S, Delaneau O, Diop G, Taing L, Montes M, et al. Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J Infect Dis. 2010 ;202(6):908-15.
Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, Maust BS, Wong KG, Troyer JL, Goedert JJ, Kessing BD, et al. Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis. 2010 ;201(4):618-26.
Smith RA, Gottlieb GS, A Miller D. Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors. Retrovirology. 2010 ;7:70.
Watson-Jones D, Wald A, Celum C, Lingappa J, Weiss HA, Changalucha J, Baisley K, Tanton C, Hayes RJ, Marshak JO, et al. Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. J Clin Microbiol. 2010 ;48(10):3496-503.
2009
Smith RA, Anderson DJ, Pyrak CL, Preston BD, Gottlieb GS. Antiretroviral drug resistance in HIV-2: three amino acid changes are sufficient for classwide nucleoside analogue resistance. J Infect Dis. 2009 ;199(9):1323-6.
Campbell MS, Gottlieb GS, Hawes SE, Nickle DC, Wong KG, Deng W, Lampinen TM, Kiviat NB, Mullins JI. HIV-1 superinfection in the antiretroviral therapy era: are seroconcordant sexual partners at risk?. PLoS One. 2009 ;4(5):e5690.
Doehle BP, Hladik F, McNevin JP, McElrath JM, Gale M. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J Virol. 2009 ;83(20):10395-405.
Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, Remington M, Magaret A, Koelle DM, Wald A, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med. 2009 ;15(8):886-92.
2008
Gottlieb GS, Hawes SE, Kiviat NB, Sow PSalif. Differences in proviral DNA load between HIV-1-infected and HIV-2-infected patients. AIDS. 2008 ;22(11):1379-80.
Gottlieb GS, Heath L, Nickle DC, Wong KG, Leach SE, Jacobs B, Gezahegne S, Wout AB van 't, Jacobson LP, Margolick JB, et al. HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. J Infect Dis. 2008 ;197(7):1011-5.
Smith RA, Gottlieb GS, Anderson DJ, Pyrak CL, Preston BD. Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitro. Antimicrob Agents Chemother. 2008 ;52(1):329-32.

Pages